How ChondroFiller injection pricing is structured

The cost of a ChondroFiller injection in the UK is driven by a single clinical variable: how much collagen scaffold the cartilage defect requires. Three main tiers apply across all joints treated — knee, hip, ankle, shoulder, and beyond — with the same ladder in place regardless of which joint is involved or how technically demanding the image-guided placement may be.

• One box of scaffold (defects up to approximately 3 cm²): £3,000
• Two boxes (defects up to approximately 4.5 cm²): £5,500
• Three boxes (defects up to approximately 6 cm²): £8,000
• Complex or multi-compartment lesions: up to £9,800

The £3,000 single-box tier is the most common starting point, reflecting the fact that many focal cartilage defects presenting for treatment fall within the smaller size range.

The clinical rationale behind the ladder is straightforward. Each box is calibrated to fill a defined defect volume; treating a larger lesion with fewer boxes than required risks insufficient matrix density, which may compromise the acellular matrix-induced chondrogenesis process by which the scaffold recruits the patient's own progenitor cells to build new tissue. In short, the number of boxes is a clinical necessity, not an arbitrary pricing variable.

Because defect surface area is the determining factor, an accurate price cannot be confirmed on the basis of symptoms alone. An MRI scan to map the lesion is a prerequisite — the measured area is the input that places a patient on the correct tier before any treatment is planned.

What the quoted price covers

Every price tier quoted above is fully all-inclusive. The figure given at the point of enquiry is the figure a patient pays — no further invoice arrives once the procedure is done.

Bundled into each tier:

• Initial consultation with Professor Paul Lee
• Review of existing MRI imaging
• Ultrasound guidance on the day of the injection
• The ChondroFiller collagen scaffold product itself
• Intravenous antibiotic cover
• A six-week follow-up appointment

Patients do not receive a separate bill for the imaging guidance, a device charge, or a clinic facility fee. The London Cartilage Clinic notes explicitly that price comparisons with other providers should account for whether those line items are bundled or added later — a sensible prompt given how variable private treatment invoicing can be.

The practical upshot is that the quoted tier figure represents the patient's total out-of-pocket cost at the treatment stage. Where private medical insurance is involved, the same bundled total is what insurers are asked to authorise — no surprises emerge after the pre-authorisation letter has been issued.

Why MRI comes before a price can be confirmed

Mapping the defect before setting the price is not a procedural hurdle — it is what makes the treatment precisely calibrated to each patient's lesion.

The defect surface area, measured on MRI, is the direct input that determines which box tier applies. Without that measurement, any figure quoted in advance would be a provisional range rather than a confirmed cost. This is why the patient journey at the London Cartilage Clinic begins with imaging review rather than a price quotation.

The scan also serves a second, equally important function: establishing clinical suitability. Whether a ChondroFiller injection is appropriate for a given defect, and which tier applies if it is, are both answered by the same imaging review. For patients whose lesion turns out to be too diffuse, too advanced, or complicated by subchondral involvement, that review clarifies the position before any clinical or financial commitment is made.

There is no stage in this pathway where a confirmed price can be issued on symptoms alone. The MRI is the point at which a personalised treatment plan — and a personalised cost — becomes possible.

NHS, private insurance, and self-funding

ChondroFiller injection has no NICE appraisal, no NHS commissioning pathway, and no active NHS pilot. That is unlikely to change in the near term, and patients should plan on a self-funded basis from the outset.

It is worth noting that this reflects the broader focal cartilage regeneration market rather than any specific shortcoming of ChondroFiller. AMIC, ACI, and MACI — the main surgical alternatives for equivalent defect sizes — sit at the same private-only level in practice for the overwhelming majority of patients. There is no funded NHS comparator being bypassed here.

Private medical insurance

Some patients find that private medical insurance covers part or all of the cost. ChondroFiller injections are billed using CCSD procedure codes W3111 (cartilage regeneration with collagen scaffold) and W8500. Approvals have been reported most consistently with Bupa, Aviva, and WPA.

Written pre-authorisation from the insurer must be obtained before the procedure is booked — retrospective claims are routinely declined. The clinic can provide the relevant procedure codes on request, so patients have what they need to put to their insurer before any appointment is scheduled. Because policy terms vary, approval is not guaranteed regardless of the insurer, and it is worth confirming coverage in writing before committing to a treatment date.

Combination therapy and programme pricing

For a minority of patients — those with more complex, multi-pathology presentations — the standard single-treatment route sits alongside more advanced options.

When cartilage loss is accompanied by significant joint inflammation or early osteoarthritis, combining the ChondroFiller injection with Arthrosamid costs £6,000. The two products address different problems: ChondroFiller is the regenerative scaffold targeting the cartilage defect itself, while Arthrosamid is a non-regenerative polyacrylamide hydrogel providing volume and cushioning support. They are not a blended treatment; each has a distinct role in the joint.

For the most complex presentations — typically multi-compartment defects or cases where mesenchymal cell support is clinically indicated — the Ultimate Tri-Active programme adds MSC therapy to the combination, bringing the total to £11,000.

A Lifetime Program offering annual MRI monitoring and bi-annual scaffold top-ups is also available for patients requiring long-term lesion management; the ongoing fee structure for this pathway is discussed at consultation, as it depends on follow-up imaging findings.

The majority of patients fall outside these advanced scenarios. The single-box, single-treatment ChondroFiller injection at £3,000 remains the most common starting point.

Getting a ChondroFiller injection at the London Cartilage Clinic

The UK's certified delivery centre for the ChondroFiller injection is the London Cartilage Clinic, located at 66 Harley Street, London. No GP referral is required — patients self-refer directly and book an initial assessment appointment; bringing any existing MRI to that first visit will allow defect mapping to begin without delay.

Professor Paul Y. F. Lee leads ChondroFiller injection delivery at the clinic. Technique precision matters here: clinical outcomes with an injectable collagen scaffold are sensitive to how and where the material is placed, which is why the same product can produce meaningfully different results depending on the practitioner.

The limited number of certified UK providers reflects regulation rather than market restriction. As a CE-marked Class III medical device — the highest implantable-device category under EU MDR — ChondroFiller can only be administered by practitioners who have completed formal certification. That requirement keeps the provider footprint small and deliberately specialised.

For patients at the early stage of considering whether the ChondroFiller injection is appropriate for their defect, the London Cartilage Clinic website at londoncartilage.com includes an eight-question self-assessment designed to help clarify likely suitability before committing to a clinical appointment. It is a useful first step for anyone still weighing options — and often the most honest way to arrive at a consultation already knowing the right questions to ask.